Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Saved in:
Bibliographic Details
Title: Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Authors: Knoll, M.1,2 (AUTHOR), Balermpas, P.3,4 (AUTHOR), von der Grün, J.5,6 (AUTHOR), Tawk, B.7,8 (AUTHOR), Adeberg, S.9,10 (AUTHOR), Tinhofer, I.11,12 (AUTHOR), Budach, V.11,12 (AUTHOR), Linge, A.13,14 (AUTHOR), Krause, M.13,14 (AUTHOR), Stuschke, M.15,16 (AUTHOR), Grosu, A.L.17,18 (AUTHOR), Zips, D.19,20 (AUTHOR), Combs, S.E.21,22 (AUTHOR), Belka, C.21,23 (AUTHOR), Kriegsmann, M.7,24 (AUTHOR), Weichert, W.21,25 (AUTHOR), Baumann, M.26 (AUTHOR), Roedel, C.3,6 (AUTHOR), Debus, J.2,8 (AUTHOR), Abdollahi, A.26,27 (AUTHOR)
Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pS161-S161. 1p.
Database: Academic Search Ultimate
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2020.07.925